Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

New blood test for improved frontotemporal dementia diagnostics

A new study by researchers at the University of Eastern Finland shows for the first time that blood-based measurement of glial fibrillary acidic protein (GFAP) enables distinguishing patients with frontotemporal dementia from those with primary psychiatric disorders or healthy individuals.

6 Jul 2021

IU researchers developing noninvasive brain stimulation technique to treat neurological disorders

Indiana University School of Medicine researchers are developing a new, noninvasive brain stimulation technique to treat neurological disorders, including pain, traumatic brain injury (TBI), epilepsy, Parkinson's disease, Alzheimer's disease and more.

2 Jul 2021

Researchers repurpose existing drugs to reduce severity of sleep apnea by at least 30%

New research published in The Journal of Physiology shows that researchers have successfully repurposed two existing medications to reduce the severity of sleep apnea in people by at least 30 per cent.

2 Jul 2021

Repurposing existing medications to reduce the severity of sleep apnea

In an Australian world-first, researchers have successfully repurposed two existing medications to reduce the severity of sleep apnea in people by at least 30 per cent.

2 Jul 2021

Research highlights long-lasting effects of childhood reading problems on cognitive skills

Reading difficulties in childhood are linked to poorer cognitive skills in older age and a greater likelihood of registering scores indicative of dementia risk, suggests research published online in the Journal of Epidemiology & Community Health.

2 Jul 2021

Tell-tale signs of high stroke risk may appear a decade in advance

The tell-tale signs of a person’s susceptibility to a stroke may appear up to 10 years before the event, suggests research published online in the Journal of Neurology Neurosurgery & Psychiatry.

2 Jul 2021

Developing AI technology to detect early signs of Alzheimer's disease

With the support of a new grant worth $3.9 million, Michigan State University researchers are developing technology that scans speech and vocabulary patterns to catch early signs of Alzheimer's disease, the most common cause of dementia.

1 Jul 2021

Flinders University trial to evaluate new blood test for personalized cancer treatment

A blood test to help guide the treatment of oesophageal, stomach and bowel cancers will be evaluated in a new Flinders University trial set to get underway.

1 Jul 2021

Study provides renewed hope for treating Alzheimer's and Parkinson's diseases

Nanosized molecules of a particular chemical element can inhibit the formation of plaque in the brain tissues. This new discovery by researchers at Umeå University, Sweden, in collaboration with researchers in Croatia and Lithuania, provides renewed hope for novel treatments of, for instance, Alzheimer's and Parkinson's disease in the long run.

1 Jul 2021

New software tool can help identify gene regulators more efficiently

A team of scientists at the University of Illinois Chicago has developed a software tool that can help researchers more efficiently identify the regulators of genes. The system leverages a machine learning algorithm to predict which transcription factors are most likely to be active in individual cells.

1 Jul 2021

Majority of people were unprepared and did not have a pandemic plan, survey reveals

Researchers point out that if these healthy individuals had a challenging time absorbing COVID-related information, then such challenges may be even greater in people with limited educational opportunities or with neurocognitive disorders, such as Alzheimer's disease or a brain injury, due to low health literacy and impaired memory.

1 Jul 2021

New research receives $2 million grant to determine if meningitis, sepsis increase Alzheimer's risk

The role of peripheral and brain infections in the development of Alzheimer's disease is the focus of new research at The University of Texas Health Science Center at Houston, funded with a $2 million grant from the National Institutes of Health.

30 Jun 2021

Researchers launch a new smell training device for rehabilitation after Covid-19

Smell training used to be mainly a thing for wine enthusiasts, gourmets, and perfumers. But Covid-19 changed all that, and now Malmö University researchers have launched a new smell training device.

30 Jun 2021

Desperate for home care, seniors often wait months with workers in short supply

For years, Louise Shackett has had trouble walking or standing for long periods, making it difficult for her to clean her house in southeastern Maine or do laundry. Shackett, 80, no longer drives, which makes it hard to get to the grocery store or doctor.

30 Jun 2021

Promising preclinical results of new dementia treatment candidate set the stage for human trials

Researchers have identified a new treatment candidate that appears to not only halt neurodegenerative symptoms in mouse models of dementia and Alzheimer's disease, but also reverse the effects of the disorders.

29 Jun 2021

LSL60101 compound improves cognitive deficit in murine models with Alzheimer’s

The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease.

29 Jun 2021

IU School of Medicine wins $30 million NIA funding to study Alzheimer’s disease and related dementias

National Centralized Repository for Alzheimer's Disease and Related Dementias grant has been renewed for another five years with funding expected to total $30 million from the National Institute on Aging (NIA), within the National Institutes of the Health.

29 Jun 2021

Advanced X-ray technology provides a viable pipeline for multiscale whole brain imaging

Researchers at the University of Chicago and the U.S. Department of Energy's (DOE) Argonne National Laboratory have leveraged existing advanced X-ray microscopy techniques to bridge the gap between MRI (magnetic resonance imaging) and electron microscopy imaging, providing a viable pipeline for multiscale whole brain imaging within the same brain.

29 Jun 2021

FDA's controversial decision to approve aducanumab for Alzheimer's treatment raises major ethical issues

The U.S. Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's disease raises at least three major ethical issues that need to be addressed, states a new article in the Hastings Center Report:

29 Jun 2021

Alternative model of Alzheimer's emphasizes different set of mechanisms that lead to neurodegeneration

In the context of recent debate over the FDA's approval of aducanumab, it's refreshing to learn about a model of Alzheimer's neurodegeneration that doesn't start with the pathogenic proteins amyloid or Tau.

29 Jun 2021

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

New blood test for improved frontotemporal dementia diagnostics

IU researchers developing noninvasive brain stimulation technique to treat neurological disorders

Researchers repurpose existing drugs to reduce severity of sleep apnea by at least 30%

Repurposing existing medications to reduce the severity of sleep apnea

Research highlights long-lasting effects of childhood reading problems on cognitive skills

Tell-tale signs of high stroke risk may appear a decade in advance

Developing AI technology to detect early signs of Alzheimer's disease

Flinders University trial to evaluate new blood test for personalized cancer treatment

Study provides renewed hope for treating Alzheimer's and Parkinson's diseases

New software tool can help identify gene regulators more efficiently

Majority of people were unprepared and did not have a pandemic plan, survey reveals

New research receives $2 million grant to determine if meningitis, sepsis increase Alzheimer's risk

Researchers launch a new smell training device for rehabilitation after Covid-19

Desperate for home care, seniors often wait months with workers in short supply

Promising preclinical results of new dementia treatment candidate set the stage for human trials

LSL60101 compound improves cognitive deficit in murine models with Alzheimer’s

IU School of Medicine wins $30 million NIA funding to study Alzheimer’s disease and related dementias

Advanced X-ray technology provides a viable pipeline for multiscale whole brain imaging

FDA's controversial decision to approve aducanumab for Alzheimer's treatment raises major ethical issues

Alternative model of Alzheimer's emphasizes different set of mechanisms that lead to neurodegeneration

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in